Use Acorda to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Acorda will likely underperform.
The median price of Acorda for the period between Mon, May 20, 2013 and Wed, Jun 19, 2013 is 33.45 with a coefficient of variation of 2.48. The daily time series for the period is distributed with a sample standard deviation of 0.83, arithmetic mean of 33.4, and mean deviation of 0.69. The Stock received substential amount of media coverage during this period.
Acorda Therapeutics Inc [ACOR] is traded on NASDAQ in USA. It is located in Acorda Therapeutics, Inc.Ardsley, NY and employs 378 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.36 B. Acorda Therapeutics Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 39.88 M outstanding shares of which 2.7 M shares are presently shorted by private and institutional investors with about 6.0 trading days to cover.
Acorda Therapeutics, Inc., a commercialstage biopharmaceutical company, engages in the identification, development, and commercialization of therapies for multiple sclerosis , spinal cord injury , and other central nervous system disorders primarily in the United States. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
0.78% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
